Severity
Low
FDA Drug recall · Reported August 25, 2021
Out of specification results for conductivity.
DuPont Nutrition USA, Inc recalled Avicel, Mirocrystalline cellulose, packaged in bulk as PH101 NF, PH102 NF, PH200 NF, Manu… - a low-severity action.
Avicel, Mirocrystalline cellulose, packaged in bulk as PH101 NF, PH102 NF, PH200 NF, Manu… was recalled by DuPont Nutrition USA, Inc in August 25, 2021. Reason: Out of specification results for conductivity.. Check the official notice for the remedy. Verify recall #D-0728-2021 with the FDA Drug before acting.
The recall
DuPont Nutrition USA, Inc issued this low-severity FDA Drug recall-Out of specification results for conductivity..
Sourced from official FDA Drug enforcement records. Verify recall #D-0728-2021 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0728-2021) was formally reported on August 25, 2021, with the manufacturer initiating the action on August 5, 2021. It is classified under Low severity (Class III), with a current status of Terminated. DuPont Nutrition USA, Inc is listed as the recalling firm, operating out of Newark, DE. Federal records list the affected scope as 2,384,720 kg.
The documented reason for this recall is: Out of specification results for conductivity. Distribution data in the federal record shows the product reached: Product was distributed nationwide, including Puerto Rico and to foreign accounts abroad.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
2,384,720 kg
Related Recalls
6
5 from same agency
Avicel, Mirocrystalline cellulose, packaged in bulk as PH101 NF, PH102 NF, PH200 NF, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711
Out of specification results for conductivity.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-0728-2021 |
| Date reported | August 25, 2021 |
| Date initiated | August 5, 2021 |
| Recalling firm | DuPont Nutrition USA, Inc |
| Firm location | Newark, DE |
| Affected scope | 2,384,720 kg |
| Distribution | Product was distributed nationwide, including Puerto Rico and to foreign accounts abroad. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported August 25, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.